Soleno Therapeutics (SLNO) Interest Coverage Ratio Growth (3y) (2016 - 2026)
Soleno Therapeutics (SLNO) Interest Coverage Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | 26.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.33% |
| Dec 31, 2025 | 592.61% |
| Sep 30, 2025 | 26.16% |
| Jun 30, 2025 | 87.41% |
| Mar 31, 2025 | -37.86% |
| Dec 31, 2024 | 3,803.16% |
| Sep 30, 2024 | 82.97% |
| Jun 30, 2024 | 73.02% |
| Sep 30, 2023 | 69.80% |
| Jun 30, 2023 | -904.54% |
| Mar 31, 2023 | -89.18% |
| Dec 31, 2022 | 94.92% |
| Sep 30, 2022 | 16.42% |
| Jun 30, 2022 | -68.31% |
| Mar 31, 2022 | -7.05% |
| Dec 31, 2021 | 22.92% |
| Sep 30, 2021 | -158.30% |
| Jun 30, 2021 | -38.31% |
| Dec 31, 2019 | -2,257.57% |
| Dec 31, 2018 | -25.99% |